Perhaps a bake sale. But then again, why bother? NA sounds like a better deal anyway.

Hi Mike:

There is no logical reason to consider collogenase ; as it would likely involve a
series of injections over time.

Needle aponevrotomy is over and done in a bout fifteen minutes with almost no discomfort.

See my testimony on the forum Nov12, 2003 entitled miraculous change.

Also see my photos at:
http://www.picturetrail.com/gallery/view?p=999&gid=3106302&uid=127194&members=1

I was advisd after my NA procedure that recurrence
was possible/likely within 2 to 4 years ; and,
a repeat NA procedure could be performed when chord
contracture prevented flattening my hand on a table,
once again (30-45 degrees contracture of my "pinkey.")
I used to think that collagenase was "the solution" and
have decided that NA is a more viable remedy becuse of
the efficincy and availability of the procedure.Typically,
a person has one or two visits with a 2-3 day post-op
interlude followed by minor cautions for about three weeks.
The collagenas injections are given over several weeks
as a substitute for the 20-30 minute needle procedure. The
chord is still "snapped" after weakening. From a practical
standpoint, I see little difference and some advantage to
the NA procedure. Factor in the time, expense, travel,
track record, location, expense and make an informed choice.
I encourage any and all with Stage two or more DD/DC to
consult someone. My personal suggestion would be an NA
practitioner from the list at the Lariboisiere site. BTC
may be a viable future option; for the near term NA has a
solid history of favorable outcomes. Check it out!

Does anyone know of a Doctor in Washington State that will or does Collagenase injections. I have DC and can still lay a flat hand on table....but the cords are starting to bulge in my palms....just like to cover my self and take care of it early.....safe then sorry .....thanks so much for the great info.........Roberta

Yes although we still discuss Collagenase on this forum, hope for its availability is fading because years of FDA Phase III trials lie ahead. Meanwhile if NA goes mainstream in the U.S., the market for it as a Dupuytren's therapy may be greatly reduced. It still has great potential for Peyronie's but I think Biospecifics has been putting all their money into Dupuytren's trials - unfortunately.

As we all know by know, the drug development process in this country is making less sense all the time.